Antibiotic Resistance in Companion and Food-Producing Animals, 2nd Edition

A special issue of Antibiotics (ISSN 2079-6382). This special issue belongs to the section "Antibiotics in Animal Health".

Deadline for manuscript submissions: 15 September 2024 | Viewed by 1827

Special Issue Editors


E-Mail Website
Guest Editor
Assistant Professor, Microbiology at the Faculty of Veterinary Medicine, University of Thessaly, Volos, Greece
Interests: antimicrobial resistance; zoonoses; molecular epidemiology;

E-Mail Website
Guest Editor
Department of Public and One Health, University of Thessaly, Volos, Greece
Interests: zoonoses; antimicrobial resistance; molecular epidemiology; biofilm production; emerging pathogens
Special Issues, Collections and Topics in MDPI journals

Special Issue Information

Dear Colleagues,

Antimicrobial resistance has been characterized as one of the most significant, but silent, pandemics at present, both at the human and veterinary level. In animals, multidrug (MDR) or pan-drug resistance (PDR) is an increasing problem despite the strict restrictions on antibiotic administration that have been imposed at a global level. Companion animals are frequently subjected to repeated ineffective treatments, consequently contributing to the development of resistance. Additionally, in food-producing animals, the widespread misuse of antibiotics has been observed, occasionally including last-line antibiotics—e.g., carbapenems. As both food-producing and companion animals are significant factors in bacterial ecology, they can serve as pools and vehicles of antibiotic resistance, which will inevitably lead to effects being observed on people.

This Special Issue aims to provide the opportunity to publish original research articles presenting the burden of antibiotic resistance in companion and food-producing animals and discussing current and future trends in antibiotic resistance and eradication approaches. This Special Issue also intends to expand our understanding of the molecular and spatial epidemiology of resistant pathogens, as well as of gene transfer among humans, animals, and the environment under the “One Health” approach. Retrospective studies in antibiotic resistance, as well as meta-analyses, would also be highly appreciated. Manuscripts dealing with novel aspects of regulatory matters are also welcome.

Here, you can find the link to this Special Issue’s first edition:

https://www.mdpi.com/journal/antibiotics/special_issues/antibio_resis_animal

Dr. Marina Sofia
Dr. Dimitris C. Chatzopoulos
Guest Editors

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Antibiotics is an international peer-reviewed open access monthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2900 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.

Keywords

  • antibiotic resistance
  • swine
  • poultry
  • livestock
  • food production
  • gene transfer
  • One Health
  • zoonoses

Published Papers (1 paper)

Order results
Result details
Select all
Export citation of selected articles as:

Research

16 pages, 1294 KiB  
Article
Multidrug-Resistant Escherichia coli Strains to Last Resort Human Antibiotics Isolated from Healthy Companion Animals in Valencia Region
by Ana Marco-Fuertes, Jaume Jordá, Clara Marin, Laura Lorenzo-Rebenaque, Laura Montoro-Dasi and Santiago Vega
Antibiotics 2023, 12(11), 1638; https://doi.org/10.3390/antibiotics12111638 - 19 Nov 2023
Cited by 3 | Viewed by 1629
Abstract
Failure in antibiotic therapies due to the increase in antimicrobial-resistant (AMR) bacteria is one of the main threats to public and animal health. In recent decades, the perception of companion animals has changed, from being considered as a work tool to a household [...] Read more.
Failure in antibiotic therapies due to the increase in antimicrobial-resistant (AMR) bacteria is one of the main threats to public and animal health. In recent decades, the perception of companion animals has changed, from being considered as a work tool to a household member, creating a family bond and sharing spaces in their daily routine. Hence, the aim of this study is to assess the current epidemiological situation regarding the presence of AMR and multidrug resistance (MDR) in companion animals in the Valencia Region, using the indicator bacteria Escherichia coli as a sentinel. For this purpose, 244 samples of dogs and cats were collected from veterinary centres to assess antimicrobial susceptibility against a panel of 22 antibiotics with public health relevance. A total of 197 E. coli strains were isolated from asymptomatic dogs and cats. The results showed AMR against all the 22 antibiotics studied, including those critically important to human medicine. Moreover, almost 50% of the strains presented MDR. The present study revealed the importance of monitoring AMR and MDR trends in companion animals, as they could pose a risk due to the spread of AMR and its resistance genes to humans, other animals and the environment they cohabit. Full article
Show Figures

Figure 1

Back to TopTop